Match each patient's clinical presentation with the autoantibody most specifically associated with their underlying immunologic pathology.
- A 28-year-old woman with a photosensitive malar rash, inflammatory arthritis, and new-onset nephrotic-range proteinuria.Anti-double-stranded DNA (anti-dsDNA) antibodies
- A 45-year-old woman with dysphagia, skin thickening restricted to her fingers and face, and episodic digital vasospasm in the cold.Anti-centromere antibodies
- A 50-year-old man with progressive symmetric proximal muscle weakness, interstitial lung disease, and violaceous papules over his knuckles.Anti-Jo-1 (anti-histidyl-tRNA synthetase) antibodies
- A 35-year-old woman with severe bilateral keratoconjunctivitis sicca, xerostomia, and an increased risk of B-cell lymphoma.Anti-Ro/SSA and anti-La/SSB antibodies
Answer
The clinical syndromes correctly map to the following markers: SLE with anti-dsDNA, CREST syndrome with anti-centromere, dermatomyositis (antisynthetase syndrome) with anti-Jo-1, and Sjögren syndrome with anti-Ro/SSA and anti-La/SSB.
Each clinical vignette presents a classic constellation of symptoms for a distinct rheumatologic or autoimmune disease. Correctly diagnosing the underlying condition from the clinical presentation allows for the accurate identification of its most specific autoantibody, which is crucial for confirming the diagnosis, assessing patient prognosis, and guiding targeted management strategies.
Step-by-Step Solution
Key Concept
Identifying specific autoantibodies for rheumatologic and autoimmune diseases based on clinical manifestations is essential for establishing an accurate diagnosis, anticipating organ involvement, and predicting disease complications.